Allergic Angiitis

Search Trials
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Status:
Unknown status
Last Changed:
Mar 3, 2017
First Changed:
Sep 15, 2015
Disease(s):
Allergic Cutaneous Vasculitis
Intervention(s):
DapsoneHLA-B*1301
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Status:
Active, not recruiting
Last Changed:
Mar 8, 2021
First Changed:
Jan 5, 2017
Disease(s):
Asthma
Intervention(s):
Benralizumab
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
Status:
Completed
Last Changed:
Jul 29, 2020
First Changed:
Dec 19, 2005
Disease(s):
Hypereosinophilic Syndromes
Intervention(s):
Mepolizumab
Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.
Status:
Recruiting
Last Changed:
Feb 10, 2022
First Changed:
May 23, 2017
Disease(s):
Eosinophilic Granulomatosis With Polyangiitis
Intervention(s):
RituximabAzathioprinePlacebo-rituximabPlacebo-azathioprine

Connect. Empower. Inspire.